| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| memantine | alpha-7 nicotinic cholinergic receptor subunit | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| memantine | dopamine d2 receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist,agonist |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | gaba(a) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| memantine | glycine receptors | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| memantine | glycine receptors | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| memantine | glycine receptors | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| memantine | glycine receptors | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| memantine | glycine receptors | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| memantine | glutamate (nmda) receptor | small molecule | NA | drugbank , DGIDB | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.07 | approved,investigational | antagonist |
| memantine | glutamate receptor ionotropic, nmda 1 | small molecule | NA | drugbank , DGIDB | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.07 | approved,investigational | binder |
| memantine | glutamate (nmda) receptor | small molecule | NA | drugbank , DGIDB | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.91 | approved,investigational | antagonist |
| memantine | glutamate (nmda) receptor | small molecule | NA | drugbank , DGIDB | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.94 | approved,investigational | antagonist |
| memantine | glutamate (nmda) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| memantine | glutamate (nmda) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| memantine | glutamate (nmda) receptor | small molecule | NA | drugbank , DGIDB | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.97 | approved,investigational | antagonist |
| memantine | glutamate (nmda) receptor | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| memantine | 5-hydroxytryptamine receptor 3a | small molecule | NA | drugbank | Behavioral Symptoms[MeSHID:D001526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| click here to return to the previous page | ||||||||